Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) recently leveraged the trademarked ability of its DehydraTECH technology to deliver cannabinoids by entering a new partnership with Cultivating Wellness Inc. (“CW”) to formulate the ChrgD+ premium brand. A recent article discussing the company reads, “LXRP’s partnership with Cultivating Wellness Inc. (“CW”), which formulated the product, is seen as an important combined effort (http://cnw.fm/qe9AH). … LXRP has not only partnered with CW as the manufacturer of ChrgD+; it also serves as the distributor of the product to its national network of customers, such as convenience stores, specialty retailers, national accounts and grocery chains. It is seen as the beginning of an important partnership between the two companies.”
To view the full article, visit http://cnw.fm/Ec3U1
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp. licenses disruptive patented delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECH™ delivery technology. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit the company’s website at www.LexariaBioscience.com.
More from CannabisNewsBreaks
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
CannabisNewsWire is at the epicenter of the Cannabis Revolution.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cannabisnewswire.com